These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 19807731)
1. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
4. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347 [TBL] [Abstract][Full Text] [Related]
5. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Lee SH; Kim J; Kim WH; Lee YM Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007 [TBL] [Abstract][Full Text] [Related]
6. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908 [TBL] [Abstract][Full Text] [Related]
7. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
8. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Magdinier F; Wolffe AP Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512 [TBL] [Abstract][Full Text] [Related]
9. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
10. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731 [TBL] [Abstract][Full Text] [Related]
11. Heparanase expression is associated with histone modifications in glioblastoma. Hong X; Nelson K; Lemke N; Kalkanis SN Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963 [TBL] [Abstract][Full Text] [Related]
12. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009 [TBL] [Abstract][Full Text] [Related]
15. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression. Larsson L; Thorbert-Mros S; Rymo L; Berglundh T Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related]
19. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]